Τετάρτη 11 Μαρτίου 2020

 British Journal of Cancer - 
Tumour-agnostic drugs in paediatric cancers
British Journal of Cancer, Published online: 12 March 2020; doi:10.1038/s41416-020-0770-5Tumour-agnostic drugs in paediatric cancers
British Journal of Cancer - Issue - nature.com science feeds
3h
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
British Journal of Cancer, Published online: 12 March 2020; doi:10.1038/s41416-020-0774-1Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
British Journal of Cancer - Issue - nature.com science feeds
3h
Tumour-agnostic drugs in paediatric cancers
British Journal of Cancer - Issue - nature.com science feeds
6h
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
British Journal of Cancer - Issue - nature.com science feeds
6h


Αναρτήθηκε από στις
Ετικέτες , , , , ,

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Εγγραφή σε: Σχόλια ανάρτησης (Atom)

Αρχειοθήκη ιστολογίου